Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Monday, June 30, 2025.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2025-12-31): -22.54.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-110.58
EARNINGS PER SHARE (EPS) AVG 3Y
-60.80
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Mobile-health Network Solutions Class A Ordinary Shares
Market Cap
$30509.00
Earnings Per Share (EPS)
N/A
TTM Avg
-110.58
3Y Avg
-60.80
5Y Avg
N/A
Market Cap
$6216.00
Earnings Per Share (EPS)
N/A
TTM Avg
-24.78
3Y Avg
156.25
5Y Avg
124.99
Market Cap
$62143.00
Earnings Per Share (EPS)
N/A
TTM Avg
-459.91
3Y Avg
-720819.96
5Y Avg
-483554.38
Market Cap
$70876.00
Earnings Per Share (EPS)
-11.16
TTM Avg
-405.74
3Y Avg
-2510.68
5Y Avg
-2758.31
Market Cap
$94144.00
Earnings Per Share (EPS)
N/A
TTM Avg
-5.39
3Y Avg
-4.78
5Y Avg
-3.78
Market Cap
$109400.00
Earnings Per Share (EPS)
-56.54
TTM Avg
-2021.61
3Y Avg
-2656.46
5Y Avg
-1785.38
Market Cap
$242924.00
Earnings Per Share (EPS)
N/A
TTM Avg
-446.18
3Y Avg
-284.47
5Y Avg
-299.57
Market Cap
$374708.00
Earnings Per Share (EPS)
N/A
TTM Avg
-48.50
3Y Avg
-108.50
5Y Avg
-157.67
Market Cap
$563178.00
Earnings Per Share (EPS)
-54.17
TTM Avg
-34.20
3Y Avg
-18.78
5Y Avg
-13.04
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | $30509.00 | N/A | -110.58 | -60.80 | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6216.00 | N/A | -24.78 | 156.25 | 124.99 |
| Akanda Corp. (AKAN)vs › | $62143.00 | N/A | -459.91 | -720819.96 | -483554.38 |
| PRF Technologies Ltd. (PRFX)vs › | $70876.00 | -11.16 | -405.74 | -2510.68 | -2758.31 |
| Psyence Biomedical Ltd. (PBM)vs › | $94144.00 | N/A | -5.39 | -4.78 | -3.78 |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109400.00 | -56.54 | -2021.61 | -2656.46 | -1785.38 |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | N/A | -446.18 | -284.47 | -299.57 |
| Niki BioSolutions, Inc. (NIKI)vs › | $374708.00 | N/A | -48.50 | -108.50 | -157.67 |
| HCW Biologics Inc. (HCWB)vs › | $563178.00 | -54.17 | -34.20 | -18.78 | -13.04 |
| CDT Equity Inc. (CDT)vs › | $670379.00 | -5669.00 | -313854.00 | -213259.50 | -170757.60 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-06-30 | -86.50 |
| 2024-06-30 | -134.66 |
| 2023-06-30 | -22.68 |
| 2022-06-30 | 0.65 |
| 2021-06-30 | -4.37 |
